Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs

Mahmoud Al Rifai, Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Chayakrit Krittanawong, Sankar D. Navaneethan, L. Parker Gregg, Laura A. Petersen, Salim S. Virani

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)

Abstract

This study using data from the Veterans Affairs (VA) administrative and clinical dataset examined determinants of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) use among patients with concomitant atherosclerotic cardiovascular disease (ASCVD) and diabetes mellitus. The aim of the present analysis was to identify barriers and facilitators associated with SGLT-2i in a real-world contemporary patient population in order to improve utilization of these guideline-directed agents.

Original languageEnglish
Pages (from-to)160-162
Number of pages3
JournalAmerican Heart Journal
Volume248
DOIs
Publication statusPublished - Jun 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs'. Together they form a unique fingerprint.

Cite this